#ma
Jagsonpal Pharma to acquire Group Pharmaceuticals' wellness portfolio
Jagsonpal Pharmaceuticals has entered into a business transfer agreement (BTA) with Group Pharmaceuticals to acquire its wellness portfolio on a going-concern basis through a slump sale.
